Cerebrolysin for vascular dementia
1Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
The Cochrane Database of Systematic Reviews
|February 27, 2013
Summary
Cerebrolysin may improve cognitive and global function in vascular dementia patients. However, more research is needed due to limited trials and short follow-up periods for routine treatment recommendations.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Vascular dementia is a prevalent neurological disorder lacking definitive treatments.
- Cerebrolysin shows potential for neurotrophic and pro-cognitive effects, but existing studies have inconsistent findings.
Purpose of the Study:
- To evaluate the efficacy and safety of Cerebrolysin for treating vascular dementia.
- To synthesize evidence from randomized controlled trials on Cerebrolysin's impact on cognitive and global function.
Main Methods:
- A systematic search of the ALOIS database was conducted for randomized controlled trials (RCTs) of Cerebrolysin in vascular dementia.
- Six RCTs involving 597 participants were included after independent selection and quality assessment by two authors.
- Data extraction and meta-analysis were performed to assess treatment effects and adverse events.
Main Results:
- Meta-analyses indicated beneficial effects of Cerebrolysin on general cognitive function (MMSE, ADAS-cog+) and global clinical function (response rates).
- No significant difference in the occurrence of non-serious adverse events was observed between Cerebrolysin and control groups.
- The observed effects suggest potential benefits for patients with mild to moderate vascular dementia.
Conclusions:
- Cerebrolysin may positively influence cognitive and global function in mild to moderate vascular dementia.
- Insufficient evidence currently supports Cerebrolysin's routine use due to limited trials, variable treatment durations, and short follow-up periods.
- Further high-quality, long-term studies are warranted to establish Cerebrolysin's role in vascular dementia management.
More Related Videos
06:24Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.